Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT04603820
Eligibility Criteria:
Inclusion Criteria:
1. The patient should have signed and dated the informed consent form (ICF). The enrollment of patients who have died is allowed.
2. Women aged ≥ 18 years.
3. Patients in one of the following situations:
* Patients with breast cancer diagnosis during pregnancy, breastfeeding or within the year after delivery.
* Patients with breast cancer who become pregnant after treatment.
* Patients with breast cancer who were subjected to any fertility preservation method prior to the start of breast cancer treatment.
4. The patients referred to in the previous section and the patients who meet these characteristics prospectively could be enrolled retrospectively upon registry opening.
5. All cases diagnosed at the same site may be included. In order to prevent duplications, in case the patient followed her treatment and follow-up at another site, she will be enrolled as per the site where the diagnosis was made, requesting information of the treatment and progression, when possible.
6. Availability of clinical, epidemiological and progress data.
Exclusion Criteria:
Patients who do not wish to participate in the study for any reason could not be included in the study.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04603820
Study Brief:
Protocol Section:
NCT04603820